News

The new drug application submitted to the FDA includes significant positive outcomes of two late stage trials, which enrolled a total of 537 patients in 28 centers across

Ankylosing spondylitis, which affects over 400,000 Americans, becomes the sixth approved indication for Celebrex in the US. Unlike other forms of arthritis that typically affect older people, ankylosing

In light of the fast track designation, Amgen and Abgenix are working toward initiating the submission of the Biologics License Application (BLA) for panitumumab in patients who have

The first phase I clinical study is expected to begin shortly and will primarily evaluate the safety of Posiphen in healthy volunteers. “The initiation of the Posiphen phase

Lysosomal acid lipase (LAL) is a naturally occurring human enzyme involved in the metabolism of certain lipids, including cholesteryl esters and triglycerides. Certain diseases are caused by or

Isolagen’s randomized, double-blind, placebo-controlled phase III trial, conducted at five sites in the US, consisted of two studies evaluating the safety and efficacy of the Isolagen Process for

The trial determined the safety of administering MetXia locally to the pancreatic tumor. The initial stage study also confirmed gene transfer at the tumor site following local delivery

According to researchers, the protein fragment operates as a guide for cell movement. It works by sensing chemicals that induce a cell to move into the right direction.

A population-based study showed that the risk of adults over 50 developing the cancer within three years after a new diagnosis of diabetes is eight times higher than